Cargando…
Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency
We describe a patient with dystonia and psychotic symptoms treated with standard doses of antipsychotics, who developed neuroleptic malignant syndrome (NMS). A 16-year-old male with a history of misuse of dextromethorphan and pseudoephedrine for recreational purpose presented with dystonia and a psy...
Autores principales: | Butwicka, Agnieszka, Krystyna, Szymańska, Retka, Włodzimierz, Wolańczyk, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245487/ https://www.ncbi.nlm.nih.gov/pubmed/24253372 http://dx.doi.org/10.1007/s00431-013-2208-z |
Ejemplares similares
-
Neuroleptic Malignant Syndrome Associated with Valproate in an Adolescent
por: Yıldırım, Veli, et al.
Publicado: (2017) -
NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997) -
Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016) -
Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023) -
Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006)